GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genotech Corp (XKRX:066830) » Definitions » Treasury Stock

Genotech (XKRX:066830) Treasury Stock : ₩0 Mil (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Genotech Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Genotech's treasury stock for the quarter that ended in Dec. 2023 was ₩0 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.


Genotech Treasury Stock Historical Data

The historical data trend for Genotech's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genotech Treasury Stock Chart

Genotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Treasury Stock
Get a 7-Day Free Trial Premium Member Only -287.64 - - - -

Genotech Semi-Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Treasury Stock Get a 7-Day Free Trial Premium Member Only -287.64 - - - -

Genotech Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.


Genotech (XKRX:066830) Business Description

Traded in Other Exchanges
N/A
Address
26-69, Gajeongbuk-ro, Yuseong-gu, Daejeon, KOR, 305-343
Genotech Corp is engaged in manufacturing basic pharmaceutical substances and biological agents.

Genotech (XKRX:066830) Headlines

No Headlines